Aleva Neurotherapeutics SA Announces MRI Approval for its directSTIM™ Deep Brain Stimulation System
Lausanne, Switzerland, 14 September 2022 – Aleva Neurotherapeutics SA, the company that pioneered Directional Deep Brain Stimulation (DBS) in Neuromodulation, announces the CE approval of its MRI labeling for the directSTIM™ DBS System, to be used in a full-body magnetic resonance imaging (MRI) environment. The directSTIM™ system, featuring a fully
27/10/2023